These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12199713)

  • 1. Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion.
    Peisajovich SG; Epand RF; Epand RM; Shai Y
    Eur J Biochem; 2002 Sep; 269(17):4342-50. PubMed ID: 12199713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.
    Ghosh JK; Peisajovich SG; Shai Y
    Biochemistry; 2000 Sep; 39(38):11581-92. PubMed ID: 10995225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.
    Samuel O; Shai Y
    Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion.
    Peisajovich SG; Samuel O; Shai Y
    J Mol Biol; 2000 Mar; 296(5):1353-65. PubMed ID: 10698638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion.
    Epand RF; Martin I; Ruysschaert JM; Epand RM
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1938-43. PubMed ID: 7811285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to the fusogenic potency of foamy virus.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 2001 Jun; 284(4):870-4. PubMed ID: 11409874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1420-5. PubMed ID: 8060322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.
    Martin I; Dubois MC; Defrise-Quertain F; Saermark T; Burny A; Brasseur R; Ruysschaert JM
    J Virol; 1994 Feb; 68(2):1139-48. PubMed ID: 8289343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
    Pritsker M; Jones P; Blumenthal R; Shai Y
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane interactions of mutated forms of the influenza fusion peptide.
    Epand RM; Epand RF; Martin I; Ruysschaert JM
    Biochemistry; 2001 Jul; 40(30):8800-7. PubMed ID: 11467940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes.
    Rapaport D; Shai Y
    J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lipid polymorphism by the feline leukemia virus fusion peptide: implications for the fusion mechanism.
    Davies SM; Epand RF; Bradshaw JP; Epand RM
    Biochemistry; 1998 Apr; 37(16):5720-9. PubMed ID: 9548958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion.
    Ghosh JK; Peisajovich SG; Ovadia M; Shai Y
    J Biol Chem; 1998 Oct; 273(42):27182-90. PubMed ID: 9765238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane destabilization by N-terminal peptides of viral envelope proteins.
    Düzgüneş N; Shavnin SA
    J Membr Biol; 1992 May; 128(1):71-80. PubMed ID: 1323686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusogenic activity of amino-terminal region of HIV type 1 Nef protein.
    Curtain CC; Separovic F; Rivett D; Kirkpatrick A; Waring AJ; Gordon LM; Azad AA
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1231-40. PubMed ID: 7848681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.
    Gray C; Tatulian SA; Wharton SA; Tamm LK
    Biophys J; 1996 May; 70(5):2275-86. PubMed ID: 9172751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.